21st Annual Peggy and Gary Edwards Distinguished ALS Lecture

About this event

“Modernizing ALS: Novel Biomarkers, Digital Outcomes and New Trial Designs”

James D. Berry, MD, MPH

Winthrop Family Scholar in ALS Sciences,

Averill Healey Endowed Chair in ALS,

Chief, Division of ALS and Motor Neuron Diseases,

Mass General Brigham Associate Neurologist, Massachusetts General Hospital

Associate Professor of Neurology,

Harvard Medical School

James D. Berry, MD, MPH, is a neurologist and clinician-investigator at Massachusetts General Hospital with a focus on amyotrophic lateral sclerosis (ALS). He is currently the Director of the Mass General Brigham (MGB) Neuroscience Institute Clinical Trials Center. He has served as Chief of the MGB Division of Motor Neuron Diseases, Director of the Neurological Clinical Research Institute, and Co-Chair of the Network of Excellence for ALS. Dr. Berry works to advance the understanding of ALS biomarkers, develop digital health technologies to monitor ALS, and identify patient reported outcome measures to improve ALS trial methodology and accelerate ALS therapy development. He is the PI of numerous ALS trials and has helped to lead a number of nationwide observational studies, including Answer ALS, the NEALS Biorepository. He is currently one of the PIs for the NIH funded, nationwide, ALL ALS. Dr. Berry is also dedicated to delivering innovative care for people with ALS incorporating telemedicine, house calls, and embracing research as a key part of ALS care.

HMH Way-finding Map